Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all
Celyad's competitors and similar companies include Bluebird Bio and Allogene Therapeutics.
 Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 1992 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations Somerville, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 17 | Employees 32338% decrease | Employees 2263% decrease |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 95.4 m | Valuation ($) 585.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) €21k (FY, 2025) | Revenue (est.) $83.8m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods €8k (FY, 2025) | Cost of goods $89.4m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit €5.9m (FY, 2025) | Gross profit ($5.6m) (FY, 2024) | Gross profit N/A |
Net income | Net income €830k (FY, 2025) | Net income ($240.7m) (FY, 2024) | Net income ($190.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 409m | Total funding raised $ 532m |
For sources of this data, please see the company profile
View Company Profiles
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View companyAllogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company